By Michele Maatouk
Date: Friday 14 Nov 2025
(Sharecast News) - Shares in Cidara Therapeutics rocketed on Friday after the biotechnology firm agreed to be taken over by Merck in $9.2bn deal.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 99.72 |
| Change Today | $ -1.17 |
| % Change | -1.16 % |
| 52 Week High | $105.66 |
| 52 Week Low | $73.47 |
| Volume | 16,430,388 |
| Shares Issued | 2,527.64m |
| Market Cap | $252,056m |
| Beta | 0.44 |
| RiskGrade | 92 |
| Strong Buy | 7 |
| Buy | 10 |
| Neutral | 11 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 28 |

| Time | Volume / Share Price |
| 16:00 | 2,434,548 @ $99.72 |
| 16:00 | 100 @ $99.72 |
| 16:00 | 1,759 @ $99.72 |
| 16:00 | 2,005 @ $99.72 |
| 16:00 | 200 @ $99.72 |
You are here: research